Grundläggande statistik
| LEI | 335800G4T2A353RDGM23 |
| CIK | 1627926 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Aurobindo Pharma Ltd.
SEC Filings (Chronological Order)
Denna sida innehåller en komplett, kronologisk lista över SEC-arkiveringar, exklusive ägande-arkiveringar som vi tillhandahåller på andra ställen.
| January 14, 2015 |
Writer’s Direct Dial EXHIBIT 4 Emmet, Marvin & Martin, LLP Counsellors at Law 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730 http://www. |
|
| January 14, 2015 |
AMERICAN DEPOSITARY SHARES (One (1) American Depositary Share represents One (1) Share) THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR EQUITY SHARES OF AUROBINDO PHARMA LTD (INCORPORATED UNDER THE LAWS OF THE REPUBLIC OF INDIA) The Bank of New York Mellon, as depositary (hereinafter called the “Depositary”), hereby certifies (i) that there have been deposited with the Depositary or it |
|
| January 14, 2015 |
LZRFY / Localiza Rent A Car SA F-6EF - - F-6EF 1 aurobindof6.htm As filed with the Securities and Exchange Commission on January 14, 2015 Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT under THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by American Depositary Receipts of AUROBINDO PHARMA LTD (Exact name of issuer of deposited securities as specified in its char |
|
| December 19, 2014 |
Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, 44th Floor New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 December 17, 2014 JPMorgan Chase Bank, N. |
|
| December 19, 2014 |
Number Each American Depositary Share represents One Share JPMORGAN CHASE BANK, N. |
|
| December 19, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Aurobindo Pharma Ltd. (Exact name of Issuer of deposited securities as specified in its charter) India (Jurisdiction of Incorporation or organization of Issuer) JPMorgan Chase Bank, N.A. (Exact name of de |
|
| December 19, 2014 |
Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A., represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Berkeley Group Holdings Plc, 333-198831) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to designate the date and t |
